Asthma (severe, persistent, patients aged 6+, adults) - omalizumab (rev TA133, TA201): Royal College of Nurses

Asthma (severe, persistent, patients aged 6+, adults) - omalizumab (rev TA133, TA201): Royal College of Nurses

Asthma (severe, persistent, patients aged 6+, adults) - omalizumab (rev TA133, TA201): Royal College of Nurses
07 March 2013
(22.71 Kb 6 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 01 March 2013